Nanox Imaging Ltd. (NASDAQ: NNOX) has entered into a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement grants SOLME responsibility for marketing, distribution, installation, training, and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services.
Commercialization will proceed following applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. Costa Rica represents Nanox's third Latin American market this year, following Argentina and Peru. This expansion underscores the company's strategic focus on penetrating underserved regions with its affordable imaging solutions.
The significance of this announcement lies in its potential to transform healthcare delivery in Costa Rica. By introducing the Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system, Nanox aims to lower barriers to adoption and improve utilization of advanced medical imaging. The system is designed for ease of use and scalability, making it suitable for various clinical settings, including those beyond traditional hospitals. This aligns with Nanox's vision to drive the world's transition to preventive healthcare by enabling earlier detection, improved clinical efficiency, and broader access to care.
Nanox's integrated end-to-end platform combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, remote radiology, health IT solutions, and a marketplace. The Nanox ecosystem includes Nanox.ARC; Nanox.AI, a suite of AI algorithms that augment CT interpretation to identify early signs of chronic disease; Nanox.CLOUD, a cloud platform for secure data management and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts; and Nanox Health IT, which delivers RIS, PACS, AI, dictation, and secure infrastructure solutions. By integrating these components, Nanox seeks to streamline workflows and support safer, more efficient care delivery.
The partnership with SOLME, a registered supplier to the CCSS, positions Nanox to gain traction in Costa Rica's public healthcare system. The CCSS is the primary provider of hospital services in the country, and its adoption of the Nanox.ARC could lead to widespread use across its network. The initial proof-of-concept registration period will allow for clinical validation and adaptation to local needs before full-scale deployment. This phased approach mitigates regulatory risks and ensures that the technology meets the specific requirements of the Costa Rican healthcare system.
For investors, this agreement signals Nanox's continued execution of its global expansion strategy. The company's ability to secure distribution partners in new markets demonstrates the commercial viability of its technology and its potential to capture share in the growing market for affordable medical imaging. As Nanox expands its footprint in Latin America, it may benefit from economies of scale and increased brand recognition, which could drive further adoption in other regions. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX.
To view the full press release, visit https://ibn.fm/C77lJ. For more information about BioMedWire, visit https://www.BioMedWire.com.
